Subjects: Biological Products -- economics and Drugs, Generic -- economics / Genre: Technical Report - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Biological Products -- economics ✖ Subjects Drugs, Generic -- economics ✖ Genre Technical Report ✖

1. Biologics in perspective: the case for generic biologic drugs

Publication:: Washington, D.C. : AARP Public Policy Institute, c2009
Subject(s):: Biological Products -- economics
Drug Approval
Drugs, Generic -- economics
Chemistry, Pharmaceutical -- economics
Drug Costs
Economics, Pharmaceutical
Health Expenditures
Patents as Topic
Humans
United States

2. A sense of déjà vu: the debate surrounding state biosimilar substitution laws

Author(s):: Purvis, Leigh, author
Publication:: Washington, D.C. : AARP Public Policy Institute, September 2014
Subject(s):: Biological Products -- economics
Biological Products -- therapeutic use
Biosimilar Pharmaceuticals -- economics
Biosimilar Pharmaceuticals -- therapeutic use
Drug Costs
Drug Substitution
Legislation, Drug
Drugs, Generic -- economics
Federal Government
State Government
Humans
United States
United States. Food and Drug Administration.
United States.